| Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline DL Hershman, C Lacchetti, RH Dworkin, EM Lavoie Smith, J Bleeker, ... Journal of clinical oncology 32 (18), 1941-1967, 2014 | 1453 | 2014 |
| Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update CL Loprinzi, C Lacchetti, J Bleeker, G Cavaletti, C Chauhan, DL Hertz, ... Journal of Clinical Oncology 38 (28), 3325-3348, 2020 | 769 | 2020 |
| Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome Sandoglobulin Guillain-Barre Syndrome Trial Group The Lancet 349 (9047), 225-230, 1997 | 763 | 1997 |
| Chemotherapy-induced peripheral neurotoxicity (CIPN): an update AA Argyriou, J Bruna, P Marmiroli, G Cavaletti Critical reviews in oncology/hematology 82 (1), 51-77, 2012 | 686 | 2012 |
| Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention W Grisold, G Cavaletti, AJ Windebank Neuro-oncology 14 (suppl_4), iv45-iv54, 2012 | 576 | 2012 |
| Interventions for preventing neuropathy caused by cisplatin and related compounds JW Albers, V Chaudhry, G Cavaletti, RC Donehower Cochrane Database of Systematic Reviews, 2014 | 483 | 2014 |
| Chemotherapy-induced peripheral neurotoxicity G Cavaletti, P Marmiroli Nature Reviews Neurology 6 (12), 657-666, 2010 | 401 | 2010 |
| Bone health in cancer: ESMO clinical practice guidelines R Coleman, P Hadji, JJ Body, D Santini, E Chow, E Terpos, S Oudard, ... Annals of oncology 31 (12), 1650-1663, 2020 | 389 | 2020 |
| CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis V Fridman, B Bundy, MM Reilly, D Pareyson, C Bacon, J Burns, J Day, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (8), 873-878, 2015 | 365 | 2015 |
| The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings G Cavaletti, DR Cornblath, ISJ Merkies, TJ Postma, E Rossi, B Frigeni, ... Annals of Oncology 24 (2), 454-462, 2013 | 362 | 2013 |
| Regional variation of Guillain-Barré syndrome AY Doets, C Verboon, B Van Den Berg, T Harbo, DR Cornblath, ... Brain 141 (10), 2866-2877, 2018 | 350 | 2018 |
| Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat G Cavaletti, G Tredici, MG Petruccioli, E Dondè, P Tredici, P Marmiroli, ... European journal of cancer 37 (18), 2457-2463, 2001 | 349 | 2001 |
| Erythropoietin both protects from and reverses experimental diabetic neuropathy R Bianchi, B Buyukakilli, M Brines, C Savino, G Cavaletti, N Oggioni, ... Proceedings of the National Academy of Sciences 101 (3), 823-828, 2004 | 346 | 2004 |
| Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat G Cavaletti, A Gilardini, A Canta, L Rigamonti, V Rodriguez-Menendez, ... Experimental neurology 204 (1), 317-325, 2007 | 335 | 2007 |
| Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools G Cavaletti, B Frigeni, F Lanzani, L Mattavelli, E Susani, P Alberti, ... European journal of cancer 46 (3), 479-494, 2010 | 332 | 2010 |
| The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy‐induced peripheral neurotoxicity: Comparison with the National Cancer Institute‐Common … G Cavaletti, B Frigeni, F Lanzani, M Piatti, S Rota, C Briani, G Zara, ... Journal of the Peripheral Nervous System 12 (3), 210-215, 2007 | 318 | 2007 |
| Frequency and clinical correlates of anti–neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy E Nobile‐Orazio, E Manfredini, M Carpo, N Meucci, S Monaco, S Ferrari, ... Annals of Neurology: Official Journal of the American Neurological …, 1994 | 314 | 1994 |
| Platinum-induced neurotoxicity and preventive strategies: past, present, and future A Avan, TJ Postma, C Ceresa, A Avan, G Cavaletti, E Giovannetti, ... The oncologist 20 (4), 411-432, 2015 | 272 | 2015 |
| Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer AA Argyriou, G Cavaletti, C Briani, R Velasco, J Bruna, M Campagnolo, ... Cancer 119 (2), 438-444, 2013 | 272 | 2013 |
| The prognosis and main prognostic indicators of Guillain-Barre syndrome A multicentre prospective study of 297 patients Italian Guillain-Barré Study Group Brain 119 (6), 2053-2061, 1996 | 253 | 1996 |
